India, July 24 -- The Government of India has issued a release:
Pharmaceuticals & Medical Devices Bureau of India (PMBI), the implementing agency of the PMBJP scheme, undertakes continuous evaluation of Jan Aushadhi Kendras (JAKs) on the basis of their sale performance. Such evaluation, along with the performance of the scheme, indicates that PMBJP has significantly improved access to quality generic medicines at affordable prices across the country, through a rapidly expanding network of Jan Aushadhi Kendras. In the last 12 years, estimated savings of about Rs.45,000 crore have accrued to citizens, when compared against the prices of branded medicines, contributing significantly to a sharp reduction in out-of-pocket expenditure by househo...